수의 보조 생식 기술 시장 보고서(2026년)
Veterinary Assistive Reproduction Technology Global Market Report 2026
상품코드 : 1938711
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,754,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,763,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,772,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수의학적 보조 생식 기술 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 36억 3,000만 달러에서 2026년에는 39억 1,000만 달러로, CAGR 7.9%로 확대할 전망입니다. 지난 수년간 성장 요인으로는 자연교배에 대한 의존, 생식기술에 대한 접근성 제한, 고품질 가축에 대한 수요 증가, 전통적 수의학 서비스, 유전적 개량 프로그램에 대한 인식 부족 등을 들 수 있습니다.

수의 보조 생식 기술 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 52억 4,000만 달러에 달하며, CAGR은 7.6%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 인공수정(AI), 체외수정(IVF), 배아 이식 기술 채택 확대, 동물 번식 센터의 확대, 유전적 개량에 대한 관심 증가, 보조생식기술(ART) 서비스를 제공하는 동물병원 증가, 디지털 생식 관리 솔루션의 통합 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 배아 이식 및 체외수정 서비스 확대, 다양한 동물의 냉동 정액 및 신선 정액 사용 증가, 동물 번식에서의 유전자 검사 서비스 성장, 초음파 진단 장비 및 첨단 생식기 도입, 호르몬 치료 및 인공수정 키트에 대한 수요 증가 등이 있습니다.

향후 축산물에 대한 수요 증가가 수의학 보조생식기술(VART) 시장의 성장을 촉진할 것으로 예측됩니다. 축산물 수요 증가는 소비자가 원하는 우수한 맛과 영양가에 대한 기대와 바람직한 특성을 가진 동물을 생산할 수 있는 사육 기술의 발전으로 인해 촉진되고 있습니다. VART는 수정과 배아 발육을 지원하여 가축 번식 효율을 향상시키고, 유전적 개량과 생산성 향상을 가져옵니다. 예를 들어 2024년 8월 영국 농업인 대표 단체인 농업원예개발위원회(AHDB)의 발표에 따르면 2023년 12월 기준 24개월령 이상 암소 사육두수는 전년 대비 5,000두 증가하여 총 23만 5,000두를 기록했습니다. 이러한 가축 수요의 확대가 수의보조생식기술 시장의 성장을 촉진하고 있습니다.

수의학 보조 생식 기술 시장의 주요 기업은 젖소의 생식 건강을 위한 첨단 킬레이트화 미네랄과 같은 혁신적인 제품에 집중하여 생식 효율을 개선하고 가축의 전반적인 건강과 생산성을 향상시키고자 노력하고 있습니다. 고급 킬레이트화 미네랄은 젖소의 번식능력과 생식능력을 향상시키기 위해 배합된 영양 보충제입니다. 예를 들어 2023년 7월 인도의 동물용 의약품 제조업체인 로덱파마(Rodek Pharma)는 유제품 동물의 생식 건강 증진을 위한 고급 킬레이트화 미네랄 사료 'CMIN H8'을 출시했습니다. 이 제품은 불임 및 생산성에 영향을 미치는 기타 건강 문제 등 유제품 산업에서 흔히 발생하는 생식 문제를 해결합니다. CMIN H8은 필수 미네랄을 킬레이트 형태로 공급함으로써 영양소의 생체 이용률을 향상시키고 유제품 동물의 생식 기관에 대한 최적의 지원을 보장합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Veterinary assistive reproduction technology encompasses a range of advanced techniques and tools designed to enhance reproductive success in animals. These methods include artificial insemination, embryo transfer, and in vitro fertilization, all aimed at improving breeding efficiency, managing genetics, and increasing reproductive success across various animal species.

The primary categories of veterinary assistive reproduction technology include services, semen, instruments, and kits and consumables. The services involve procedures such as artificial insemination, embryo transfer, and in vitro fertilization, applied to animals such as cattle, pigs, sheep, goats, horses, and others. These services are distributed through both private and public channels. The technology supports various end users, including veterinary clinics and hospitals, animal breeding centers, research institutions, and universities.

Tariffs have impacted the veterinary assistive reproduction technology market by increasing costs for imported instruments, semen, kits, and consumables. Segments such as embryo transfer instruments, AI kits, and frozen semen are most affected, particularly in regions like North America and Europe. Despite higher costs, tariffs encourage local manufacturing, promote development of cost-effective reproductive solutions, and drive innovation in genetic testing and reproductive management services.

The veterinary assistive reproduction technology market research report is one of a series of new reports from The Business Research Company that provides veterinary assistive reproduction technology market statistics, including veterinary assistive reproduction technology industry global market size, regional shares, competitors with a veterinary assistive reproduction technology market share, detailed veterinary assistive reproduction technology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary assistive reproduction technology industry. This veterinary assistive reproduction technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary assistive reproduction technology market size has grown strongly in recent years. It will grow from $3.63 billion in 2025 to $3.91 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to reliance on natural breeding, limited access to reproductive technologies, growing demand for high-quality livestock, traditional veterinary services, low awareness of genetic improvement programs.

The veterinary assistive reproduction technology market size is expected to see strong growth in the next few years. It will grow to $5.24 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to adoption of ai, ivf, and embryo transfer technologies, expansion of animal breeding centers, increasing focus on genetic improvement, growth of veterinary clinics offering ART services, integration of digital reproductive management solutions. Major trends in the forecast period include expansion of embryo transfer and ivf services, increasing use of frozen and fresh semen across species, growth of genetic testing services in animal breeding, adoption of ultrasound and advanced reproductive instruments, rising demand for hormonal treatment and ai kits.

The rising demand for livestock is expected to drive the growth of the veterinary assistive reproduction technology (VART) market going forward. Increasing demand for livestock is fueled by consumer expectations for superior taste and nutritional value, as well as advancements in breeding technologies that produce animals with desirable traits. VART improves livestock breeding efficiency by supporting fertilization and embryo development, resulting in enhanced genetic improvement and productivity. For example, in August 2024, according to the Agriculture and Horticulture Development Board, a UK-based levy board representing farmers, as of December 2023, the number of female cattle older than 24 months increased by 5,000 head from the previous year, reaching a total of 235,000. Therefore, the growing demand for livestock is driving the veterinary assistive reproduction technology market.

Leading players in the veterinary assistive reproduction technology market are focusing on innovative products, such as advanced chelated minerals for the reproductive health of dairy animals, to improve reproductive efficiency and enhance overall livestock health and productivity. Advanced chelated minerals are dietary supplements formulated to improve fertility and reproductive performance in dairy cattle. For example, in July 2023, Rodec Pharma Limited, an India-based manufacturer of veterinary medicines, introduced CMIN H8, an advanced chelated mineral feed designed to enhance the reproductive health of dairy animals. This product addresses common reproductive challenges in the dairy industry, such as infertility and other health-related issues that can affect productivity. By providing essential minerals in a chelated form, CMIN H8 improves nutrient bioavailability, ensuring optimal support for the reproductive systems of dairy animals.

In March 2024, Calibre Scientific, a US-based life sciences company, acquired Microm UK for an undisclosed amount. Through this acquisition, Calibre Scientific aims to expand its portfolio in assisted reproductive technologies, strengthen its commitment to reproductive health, grow its customer base in key markets, and introduce complementary consumable products to its existing assisted reproductive technology (ART) instruments. Microm UK is a UK-based provider of assisted reproductive technology solutions.

Major companies operating in the veterinary assistive reproduction technology market are Zoetis Inc., Merck Animal Health, IDEXX Laboratories Inc., Neogen Corporation, Genus plc, ABS Global Inc., Cryoport Inc., Minitube International Inc., Semex Alliance, Select Sires Inc., Cogent Breeding Ltd., Trans Ova Genetics LLC, Viking Genetics, Vytelle Inc., Agtech Inc., IMV Technologies, MOFA Global Inc., Emlab Genetics, Avantea Srl, Alta Genetics Inc., Aberekin S.L.

North America was the largest region in the veterinary assistive reproduction technology market in 2025. The regions covered in the veterinary assistive reproduction technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary assistive reproduction technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary assistive reproduction technology market includes revenues earned by entities by providing services such as semen cryopreservation, estrus synchronization, ovum pick-up (OPU), cloning, genetic preservation, and animal breeding. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary assistive reproduction technology market also consists of sales of embryo transfer kits, semen collection systems, cryopreservation equipment, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Assistive Reproduction Technology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary assistive reproduction technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary assistive reproduction technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary assistive reproduction technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Veterinary Assistive Reproduction Technology Market Characteristics

3. Veterinary Assistive Reproduction Technology Market Supply Chain Analysis

4. Global Veterinary Assistive Reproduction Technology Market Trends And Strategies

5. Veterinary Assistive Reproduction Technology Market Analysis Of End Use Industries

6. Veterinary Assistive Reproduction Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Assistive Reproduction Technology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Veterinary Assistive Reproduction Technology Total Addressable Market (TAM) Analysis for the Market

9. Veterinary Assistive Reproduction Technology Market Segmentation

10. Veterinary Assistive Reproduction Technology Market Regional And Country Analysis

11. Asia-Pacific Veterinary Assistive Reproduction Technology Market

12. China Veterinary Assistive Reproduction Technology Market

13. India Veterinary Assistive Reproduction Technology Market

14. Japan Veterinary Assistive Reproduction Technology Market

15. Australia Veterinary Assistive Reproduction Technology Market

16. Indonesia Veterinary Assistive Reproduction Technology Market

17. South Korea Veterinary Assistive Reproduction Technology Market

18. Taiwan Veterinary Assistive Reproduction Technology Market

19. South East Asia Veterinary Assistive Reproduction Technology Market

20. Western Europe Veterinary Assistive Reproduction Technology Market

21. UK Veterinary Assistive Reproduction Technology Market

22. Germany Veterinary Assistive Reproduction Technology Market

23. France Veterinary Assistive Reproduction Technology Market

24. Italy Veterinary Assistive Reproduction Technology Market

25. Spain Veterinary Assistive Reproduction Technology Market

26. Eastern Europe Veterinary Assistive Reproduction Technology Market

27. Russia Veterinary Assistive Reproduction Technology Market

28. North America Veterinary Assistive Reproduction Technology Market

29. USA Veterinary Assistive Reproduction Technology Market

30. Canada Veterinary Assistive Reproduction Technology Market

31. South America Veterinary Assistive Reproduction Technology Market

32. Brazil Veterinary Assistive Reproduction Technology Market

33. Middle East Veterinary Assistive Reproduction Technology Market

34. Africa Veterinary Assistive Reproduction Technology Market

35. Veterinary Assistive Reproduction Technology Market Regulatory and Investment Landscape

36. Veterinary Assistive Reproduction Technology Market Competitive Landscape And Company Profiles

37. Veterinary Assistive Reproduction Technology Market Other Major And Innovative Companies

38. Global Veterinary Assistive Reproduction Technology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Assistive Reproduction Technology Market

40. Veterinary Assistive Reproduction Technology Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기